mRNA-1083
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for mRNA-1083, covering 2025-06-13 to 2025-10-14. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine) [Phase 2]